ProfileGDS4718 / 229910_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 72% 71% 81% 71% 71% 61% 60% 69% 77% 72% 71% 69% 63% 65% 59% 65% 77% 65% 55% 82% 73% 74% 68% 79% 70% 52% 78% 59% 74% 56% 60% 65% 72% 59% 64% 70% 64% 80% 72% 87% 76% 62% 72% 55% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.0448872
GSM549102patient 115, normal, homogenized [OPG study]6.9541171
GSM549104patient 119, normal, homogenized [OPG study]8.0260281
GSM549108patient 138, normal, homogenized [OPG study]6.8790771
GSM549119patient 077, normal, homogenized [OPG study]6.9347371
GSM549133patient 032, cancer, homogenized [OPG study]6.2079661
GSM549139patient 042, cancer, homogenized [OPG study]6.1224160
GSM549099patient 107, normal, homogenized [OPG study]6.7367369
GSM549109patient 139, normal, homogenized [OPG study]7.5292977
GSM549110patient 046, normal, homogenized [OPG study]7.0178572
GSM549114patient 063, normal, homogenized [OPG study]6.9499771
GSM549122patient 082, normal, homogenized [OPG study]6.8294469
GSM549134patient 033, cancer, homogenized [OPG study]6.3106363
GSM549136patient 036, cancer, homogenized [OPG study]6.451765
GSM549140patient 044, cancer, homogenized [OPG study]6.0220859
GSM549111patient 047, normal, homogenized [OPG study]6.5292565
GSM549113patient 057, normal, homogenized [OPG study]7.6386477
GSM549132patient 031, cancer, homogenized [OPG study]6.478965
GSM549137patient 038, cancer, homogenized [OPG study]5.817155
GSM549142patient 047, cancer, homogenized [OPG study]7.7904182
GSM549100patient 110, normal, homogenized [OPG study]7.0753473
GSM549107patient 135, normal, homogenized [OPG study]7.2059874
GSM549115patient 068, normal, homogenized [OPG study]6.7138568
GSM549116patient 072, normal, homogenized [OPG study]7.7571979
GSM549120patient 078, normal, homogenized [OPG study]6.8566670
GSM549131patient 030, cancer, homogenized [OPG study]5.6026252
GSM549118patient 074, normal, homogenized [OPG study]7.6576578
GSM549129patient 027, cancer, homogenized [OPG study]6.0598159
GSM549123patient 088, normal, homogenized [OPG study]7.2205874
GSM549124patient 006, cancer, homogenized [OPG study]5.8581356
GSM549126patient 015, cancer, homogenized [OPG study]6.1042160
GSM549128patient 025, cancer, homogenized [OPG study]6.4960165
GSM549103patient 117, normal, homogenized [OPG study]6.9703872
GSM549117patient 073, normal, homogenized [OPG study]6.0209659
GSM549138patient 041, cancer, homogenized [OPG study]6.4165364
GSM549141patient 045, cancer, homogenized [OPG study]6.9842970
GSM549130patient 028, cancer, homogenized [OPG study]6.3899664
GSM549101patient 111, normal, homogenized [OPG study]7.8421280
GSM549105patient 128, normal, homogenized [OPG study]7.0166272
GSM549106patient 134, normal, homogenized [OPG study]8.9391187
GSM549112patient 048, normal, homogenized [OPG study]7.4198376
GSM549125patient 011, cancer, homogenized [OPG study]6.2473462
GSM549127patient 024, cancer, homogenized [OPG study]7.1693672
GSM549135patient 035, cancer, homogenized [OPG study]5.8058255